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Objective: To date, there are no published reports comparing hemodynamically (Hd)-stable and Hd-unstable patients
with ruptured abdominal aortic aneurysms (r-AAAs) undergoing endovascular aneurysm repair (EVAR). This study
evaluates outcomes of EVAR for r-AAA based on patient’s Hd status
Methods: From 2002 to 2011, 136 patients with r-AAAs underwent EVAR and were categorized into two groups based on
systolic blood pressure (SBP) measurements before EVAR: 92 (68%) Hd-stable (SBP $80 mm Hg) and 44 (32%)
Hd-unstable (SBP <80 mm Hg for >10 minutes). All data were prospectively entered in a database and retrospectively
analyzed. Outcomes included 30-day mortality, postoperative complications, the need for secondary reinterventions, and
midterm mortality. The effect of potential predictors on 30-day mortality was assessed by c2 and logistic regression.
Results: Of the 136 r-AAA patients with EVAR, the Hd-stable and Hd-unstable groups had similar comorbidities
(coronary artery disease, 63% vs 59%; hypertension, 72% vs 75%; chronic obstructive pulmonary disease, 21% vs 26%; and
chronic renal insufﬁciency, 18% vs 18%), mean AAA maximum diameter (6.6 vs 6.4 cm), need for on-the-table conversion
to open surgical repair (3% vs 7%), and incidences of nonfatal complications (43% vs 38%) and secondary interventions
(23% vs 25%). Preoperative computed tomography scan was available in signiﬁcantly fewer Hd-unstable patients (64% vs
100%; P < .05). Compared with Hd-stable patients, the Hd-unstable patients had a signiﬁcantly higher intraoperative
need for aortic occlusion balloon (40% vs 6%; P < .05), mean estimated blood loss (744 vs 363 mL; P < .05), incidence of
developing abdominal compartment syndrome (ACS; 29% vs 4%; P < .01), and death (33% vs 18%; P < .05). ACS was
a signiﬁcant predictor of death; death in all r-EVAR with ACS was signiﬁcantly higher compared with all r-EVAR
without ACS (10 of 17 [59%] vs 22 of 119 [18%]; P < .01).
Conclusions: EVAR for r-AAA is feasible in Hd-stable and Hd-unstable patients, with a comparable incidence of
conversion to open surgical repair, nonfatal complications, and secondary interventions. Hd-stable patients have reduced
mortality at 30 days, whereas Hd-unstable patients require intraoperative aortic occlusion balloon more frequently, and
have an increased risk for developing ACS and death. (J Vasc Surg 2013;57:1255-60.)The evolution of endovascular aneurysm repair (EVAR)
has led to improvements in our ability to treat elective and
ruptured abdominal aortic aneurysms (r-AAAs).1-3
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://dx.doi.org/10.1016/j.jvs.2012.11.042widespread acceptance of an EVAR-ﬁrst approach for all
patients with r-AAAs is our limited understanding in
managing hemodynamically (Hd) unstable r-AAA patients
by endovascular means and the lack of data on outcomes
of Hd-stable vs Hd-unstable patients with r-AAAs under-
going EVAR. This prospective nonrandomized study was
based on an EVAR-ﬁrst approach for all r-AAA patients
and evaluates outcomes based on patient’s Hd status.METHODS
In 2002, we established a protocol-oriented approach
for treating patients with r-AAAs.4 In the emergency
room, Hd-stable patients undergo expeditious computed
tomography (CT) scan and are subsequently transferred
to the operating room (OR), and Hd-unstable patients
are directly transferred to the OR without a preoperative
CT scan for an endovascular-ﬁrst approach and conversion
to open surgical repair (OSR) as needed. As long as the
patients maintain a measurable blood pressure, the tech-
niques of hypotensive hemostasis by limiting the resuscita-
tion to maintain a detectable blood pressure can help
minimize ongoing hemorrhage. Earlier in our experience1255
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for ruptured EVAR (r-EVAR) without the availability of
a preoperative CT scan. In such instances, aortic neck
measurements were performed on the basis of intraopera-
tive angiography only. In cases of juxtarenal r-AAAs, the
decision for conversion to OSR vs one or both renal artery
coverage was at the discretion of the vascular surgeon.
All procedures were performed in the OR with general,
regional, or local anesthesia via a femoral cutdownor a percu-
taneous approach. The stent grafts used were currently
approved by the U.S. Food and Drug Administration and
available off the shelf and included the Excluder (W. L.
Gore & Associates, Flagstaff, Ariz), Zenith (Cook Inc,
Bloomington, Ind), and AneuRx and Talent (Medtronic
AVE, Santa Rosa, Calif). Patient selection for EVAR vs
OSR, as well as the selection of particular stent grafts, was
at the discretion of the surgeon and determined primarily
by the anatomic limitations of the patient’s aortoiliac
morphology. The stent grafts were oversized 20% to 30%
relative to angiographic aortic neck measurements.
All patients without a preoperative CT scan had a post-
EVAR CT scan that conﬁrmed r-AAA. Our algorithm for
management of r-AAAs by EVAR has been detailed previ-
ously.4 Patient selection for EVAR or OSR depended on the
surgeon’s discretion and experience. During r-EVAR, stent
grafts were chosen on the basis of availability and the patient’s
aortoiliac morphology. With experience, particularly during
the past 5 years, most vascular surgeons in our group have
the ability and are comfortable with r-EVAR, resulting in
less bias toward OSR in Hd-stable as well as Hd-unstable
patients, and improvements in our ability to treat patients
with increasing complexity of aortoiliac morphology. In this
data set we accepted the real-world scenario clinical bias that
vascular surgeons face when evaluating r-AAA patients for
r-EVAR vs OSR. Patients who underwent OSR were not
included in this analysis.
The r-EVAR procedure. The patients are placed
supine and are prepared and draped. Femoral access
(surgical cutdown or percutaneous) is obtained using a
needle, ﬂoppy guidewire, and a guiding catheter. The
ﬂoppy guidewire is exchanged for a super-stiff wire that
can be used to place a large sheath (12F-14F, 30-45 cm
length) in the ipsilateral femoral artery, and the sheath is
advanced to the juxtarenal abdominal aorta so it is ready to
be used to deliver and support the aortic occlusion balloon
(AOB), if needed. Access is subsequently obtained from
contralateral femoral artery (cutdown or percutaneous) in
similar fashion and a marker ﬂush-catheter advanced to the
juxtarenal aorta for an arteriogram.
Our standard approach has been to perform r-EVAR
under general anesthesia with femoral artery cutdown.
We have reserved the percutaneous approach for EVAR
of r-AAA in select Hd-unstable patients who can cooperate
with the anesthesiologist and the vascular surgeon/
interventionists. In these patients, we prefer percutaneous
femoral artery access without a closure device, advance an
appropriately sized sheath 18F-22F as needed, and carry
out the r-EVAR. At the completion of the endovascularprocedure, the femoral sheaths are removed via the femoral
artery cutdown and direct femoral artery repair.
The placement of the stent graft main body is planned
based on the aortoiliac morphology that is best suited for
r-EVAR. Unless prohibitive, in Hd-stable patients, the
AOB is removed from the initial ipsilateral side after the
initial arteriogram and the stent graft main body advanced
under ﬂuoroscopic guidance, which limits the number of
catheter exchanges. In Hd-unstable patients who require
inﬂation of the AOB, the marker ﬂush-catheter is ex-
changed for the stent graft main body, which is delivered
up to the renal arteries. An arteriogram is done via the
sheath that is used to support the AOB, the tip of the stent
graft main body is aligned with the lowermost renal artery,
the AOB is subsequently deﬂated and withdrawn back with
the delivery sheath into the AAA, and the stent graft main
body is deployed. The remainder of the EVAR procedure is
performed similar to as in elective circumstances.
In patients with Hd instability or anatomic limitations
that precluded expeditious exclusion of the r-AAA, modular
bifurcated stent grafts were converted to aortouniiliac (AUI)
devices by deploying aortic cuffs (AneuRx, Excluder, or
Zenith Renu AUI converter) or a second aortic stent graft
main body across the stent graft ﬂow divider. The contralat-
eral iliac artery was interrupted by open ligation, endolumi-
nal occlusion, or placement of a covered stent from the
internal iliac artery into the external iliac artery, and femoro-
femoral bypass was performed.
Patient Hd status was categorized according to vital
signs any time before the r-EVAR; patients with systolic
blood pressure (SBP) measurements of <80 mm Hg for
>10 minutes in duration were categorized as Hd-unstable,
and all other patients (SBP >80 mm Hg) were considered
Hd-stable for this analysis. The diagnosis of abdominal
compartment syndrome (ACS) was made on the basis of
bladder pressures >35 mm Hg with severe abdominal
distention, or cardiovascular collapse, or both. All data
were prospectively collected, and statistical analysis was per-
formed using c2 and life-table methods.
RESULTS
In our single-center experience, from2002 to 2011, 283
patients presented with r-AAAs, of which 136 underwent
r-EVAR and were categorized into two groups by their peri-
operative Hd status: 92 (68%) were considered Hd-stable,
and 44 (32%) were Hd-unstable. Both groups were similar
with respect to comorbidities, including coronary artery
disease, deﬁned as patients with prior cardiac workup who
were deemed so by their cardiologist, presence of coronary
artery disease (63% vs 59%), hypertension (72% vs 75%),
chronic obstructive pulmonary disease, deﬁned as anyone
with asthma, emphysema, with or without home oxygen
dependency (21% vs 26%), and chronic renal insufﬁciency,
deﬁned as creatinine level >1.8 mg/dL (18% vs 18%), and
maximum AAA diameter (6.6 vs 6.4 cm; Table I). There
were notable differences between the groups in that before
r-EVAR, a preoperative CT scan was available in a signiﬁ-
cantly higher percentage of Hd-stable than in Hd-unstable
Table II. Perioperative variables in hemodynamically
(Hd) stable vs unstable patients
Variablea Hd-stable Hd-unstable P
Patients 92 (68.0) 44 (32.0)
Preoperative CT available 92 (100) 29.0 (64.0) <.05
Aortic occlusion balloon 5.0 (5.0) 18.0 (41.0) <.05
Blood loss 6 SD, mL 363.0 6 320
(50-2000)
744.0 6 692
(50-2500)
<.01
ACS 4.0 (4.0) 13.0 (29.0) <.01
Conversion to surgical repair 3.0 (3.0) 3.0 (7.0) .21
Nonfatal complications 35.0 (38.0) 19.0 (42.0) .13
Secondary interventions 23.0 (25.0) 10.0 (22.0) .16
ACS, Abdominal compartment syndrome; CT, computed tomography;
SD, standard deviation.
aCategoric data are presented as number (%) and continuous data as mean
(range).
Table I. Demographics of ruptured endovascular
aneurysm repair (r-EVAR) patients
Variablea Hd-stable Hd-unstable
Patients 92 (68.0) 44 (32.0)
AAA size, cm 6.4 (4.4-8.8) 6.6 (4.7-10.8)
Male sex 64.0 (70.0) 30.0 (67.0)
Age, years 74.0 (48-93) 73.0 (51-89)
Coronary artery disease 57.0 (63.0) 27.0 (59.0)
Hypertension 65.0 (71.0) 34.0 (76.0)
Chronic renal insufﬁciencyb 16.0 (18.0) 8.0 (18.0)
COPD 18.0 (20.0) 11.0 (24.0)
AAA, Abdominal aortic aneurysm; COPD, chronic obstructive pulmonary
disease; Hd, hemodynamically.
aCategoric data are shown as number (%) and continuous data as mean
(range).
bDeﬁned as a creatinine level >1.8 mg/dL.
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Furthermore, when compared with Hd-stable patients, the
Hd-unstable patients had a signiﬁcantly higher intraopera-
tive need for the AOB (18 of 44 [41%] vs 5 of 92 [5%];
P < .05), higher mean estimated blood loss (744 vs 363
mL; P < .01), a higher incidence of developing ACS (29%
vs 4%; P < .05), and a nonsigniﬁcant trend toward a higher
incidence of conversion to OSR (3.2% vs 6.8%; Table II).
Of the 15 patients without a preoperative CTA, one patient
was converted to OSR, three patients with normal renal
function underwent unilateral renal artery coverage, and
one patient with chronic renal insufﬁciency underwent bilat-
eral renal artery coverage. The patient who required conver-
sion toOSRdied. All unilateral renal artery coverage patients
survived without the need for dialysis, and the bilateral renal
artery coverage patient survived and currently requires
dialysis.
Table II also indicates there were no signiﬁcant differ-
ences between the Hd-stable and Hd-unstable groups in
the incidence of nonfatal complications, including myocar-
dial infarction, ischemic colitis, bleeding, wound infection,
pulmonary, renal insufﬁciency, or multisystem organ failure
(43% vs 38%), and the need for secondary interventions,
including proximal or distal stent graft extensions, use of Pal-
maz stents at the proximal aortic neck for treatment of type I
endoleaks, translumbar embolization for type II endoleaks,
or stent graft explant (23% vs 25%) over a mean follow-up of
29 months. In all r-AAA patients, the overall incidence of
ACS was 13% (17 of 136), and the overall mortality rate
was 24% (32 of 136). Although the overall incidence of
ACS after r-EVAR was only 13%, the incidence of ACS
was signiﬁcantly higher in the Hd-unstable patients than in
the Hd-stable patients (13 [29%] vs 4 [4%]; P < .01). Simi-
larly, although the overall 30-day mortality of r-EVAR was
24%, this incidence was signiﬁcantly higher in Hd-unstable
patients than in Hd-stable patients (15 [33%] vs 17 [18%];
P < .05; Table III). Univariate analysis indicated ACS to
have a signiﬁcant impact on mortality in that the incidence
of death in all r-EVAR with ACS was signiﬁcantly higher
compared with all r-EVAR without ACS (10 of 17 [59%]
vs 22 of 119 [18%]; P < .01).During the initial hospitalization after r-EVAR, three
patients required additional secondary interventions: one
required Palmaz stent placement for treatment of type I
endoleak, one required additional proximal stent graft exten-
sion for type I endoleak, and one required embolization
for type II endoleak. There were no differences among
Hd-stable and Hd-unstable patients. Among survivors,
secondary interventions for graft-related complications
were performed in 21 of 91 patients (23.1%). Most were
translumbar coil embolization procedures for persistent
type II endoleaks (12 [13.2%]). Three patients (3.3%) with
type I endoleaks had Palmaz stents placed at the aortic
neck, one (1.1%) with stent graft migration from the prox-
imal aortic neck required stent graft extension, and one
(1.1%) required conversion to OSR. Two patients (2.2%)
needed femorofemoral crossover for limb thrombosis.
Three (3.3%) patients hadmajor graft-related complications:
two had stent graft infections and required explantationwith
anaxillobifemoral bypass, andonepatient sustained a rupture
at 29 months. Complications among the 91 survivors of
EVAR for r-AAA were acute compartment syndrome or
ACS (six [6.6%]), colon ischemia (ﬁve [5.5%]; three required
colectomy), respiratory failure requiring ventilation (ﬁve
[5.5%]), and small bowel obstruction, lower extremity
thrombosis, acute renal failure requiring dialysis, multi-
system organ failure, prolonged ileus, and pulmonary embo-
lism in one patient (1.1%) each. Again, there were no
signiﬁcant differences among Hd-stable and Hd-unstable
patients.DISCUSSION
During the past decade, the proportion of r-AAA
patients being treated by EVAR is steadily increasing, and
there is ample evidence of safety and efﬁcacy of these
procedures in academic tertiary medical centers as well as
in community hospitals.5-11 In 2002, we established a stan-
dardized r-EVAR-ﬁrst approach for all patients presenting
with r-AAAs,12 and this enabled us to evaluate and
compare outcomes of Hd-stable and Hd-unstable patients
undergoing r-EVAR. Our ﬁndings of 136 r-EVAR patients
Table III. Abdominal compartment syndrome (ACS)
and mortality difference in hemodynamically (Hd) stable
vs unstable patients
Variable
Hd-stable,
No. (%)
Hd-unstable,
No. (%) P
Patients 91 (67.0) 45 (33.0)
ACS 4 (4.0) 13 (29.0) <.01
30-day mortality 17 (18.0) 15 (33.0) <.05
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unstable at presentation, and these patients have several
signiﬁcant differences compared with the Hd-stable group,
in that only two-thirds had a preoperative CT scan before
r-EVAR, they require AOB more frequently, have a higher
incidence of developing ACS, and have a higher 30-day
mortality. Furthermore, ACS was a signiﬁcant predictor
of death: the mortality rate in all r-EVAR with ACS was
59% compared with 11% in all r-EVAR without ACS.
Today, most well-established centers performing emer-
gent aortic procedures have developed strategies that facili-
tate a seamless transition of the patient from the emergency
department to the OR for r-EVAR. Although the standard-
ization of any approach will vary from one institution to
another, the fundamentals are simple: success depends on
the early diagnosis of r-AAA, the ability to have an expedi-
tious CT scan to evaluate the aortoiliac morphology, and
quick transition of the patient from the emergency depart-
ment to the OR, which is equipped to perform EVAR as
well as OSR under these emergent circumstances.4,7
The Hd status of the r-AAA patient often inﬂuences
our decision about the type of repair, be it EVAR or OSR.
Although a preoperative CT scan is not considered a neces-
sity for planning for an emergent OSR, most would agree
that a preoperative CT is of paramount importance during
emergent EVAR planning. So the question is whether one
has the time to get an emergent CT scan before EVAR,
and if not, are other tools available that might help us
manage these Hd-unstable patients by endovascular means?
Lloyd et al13 published data on a time-to-death study in
patients with r-AAAs who did not undergo treatment. Their
ﬁndings indicated that 88% (49 of 56) of patients died >2
hours after admission with the diagnosis of r-AAA. Similarly,
Sadat et al14 in their meta-analysis of 23 published studies
on r-AAAs reporting 7040 patients, with 730 (10%) under-
going EVAR, found that most patients with r-AAAs had
time for a preoperative CT scan. In our experience before
r-EVAR, although 36% (15 of 44) of Hd-unstable patients
did not have a preoperative CT scan, this subset of patients
account for our earlier experience, and during the past
several years, it is rare for a patient not to have a CT scan
before arrival to the OR.
In patients without a preoperative CT, the proximal
and distal stent graft attachment site measurements were
based on angiography alone. In such instances, stent grafts
were oversized 20% to 30% according to angiographic ﬁnd-
ings rather than the standard 10% to 20% as suggested bymost stent graft instructions for use. A subset analysis of
this patient cohort indicates no signiﬁcant differences in
achieving successful r-EVAR and aneurysm exclusion in
patients with and without preoperative CT scans; however,
the overall Hd-unstable patient cohort did have a higher
mean estimate blood loss and a higher incidence of devel-
oping ACS, and there might be some unrecognized corre-
lations among these groups. Before r-EVAR we certainly
would recommend developing systems that allow for
obtaining a preoperative CT scan in all patients. During
the past 2 years, improvements in our r-EVAR protocol
have resulted in our ability to obtain preoperative CT scans
in all r-AAA patients.
Depending on one’s comfort level and the logistics,
EVAR for rupture can be performed under local anesthesia
via percutaneous approach to general anesthesia and
femoral artery cutdown. The potential beneﬁts of local
anesthesia and a percutaneous approach are that it might
avoid the loss of sympathetic tone in the compromised
r-AAA patients.15 Although earlier in our experience we
routinely performed femoral artery cutdown for all r-AAA
patients, similar to others, we have evolved to a percuta-
neous approach for select patients, particularly those who
are Hd-unstable.16 In Hd-stable patients, particularly in
the hands of experienced operators, these percutaneous
procedures are quite feasible, and this approach needs to
be individualized on the basis of the patient’s access suit-
ability and Hd status. In our experience, percutaneous
techniques were used in 43.2% (19 of 44) of Hd-
unstable patients during r-EVAR, and there were no signif-
icant differences on outcomes among these groups.
Overall, 17% (23 of 136) of all r-EVAR patients required
the AOB. The need for AOB was signiﬁcantly higher in Hd-
unstable patients than in Hd-stable patients (41% vs 5%;
P < .05), and 65% (15 of 23) of patients requiring the
AOB developed ACS. Univariate analysis indicated the
need for AOB during r-EVAR was an independent signiﬁ-
cant risk factor for developing ACS.17 The appropriate use
of AOB is Hd-unstable patients is vital to the success of
EVAR in these emergent circumstances. Our preferred
method for placing AOBs is to use the femoral approach,
and we have found this to have several advantages:
1. It allows the anesthesia team to have access to both
upper extremities for arterial and venous access;
2. Patients who require the AOB are often hypotensive
and percutaneous brachial access in these patients can
be difﬁcult and more time-consuming than femoral
cutdown; and
3. The currently available AOBs require at least a 12F
sheath, which requires a brachial artery cutdown
and repair, and stiff wires and catheters across the
aortic arch without prior imaging under emergent
circumstances might lead to other arterial injuries
or embolization causing stroke.
If inﬂation of the AOB is required to maintain a viable
blood pressure, then the remainder of the EVAR should be
JOURNAL OF VASCULAR SURGERY
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sion, and further limit the development of complications
of ongoing bleeding such as ACS and multisystem organ
failure.17 During the procedure, just before deployment
of the stent graft main body, the AOB should be deﬂated
from the suprarenal level and withdrawn. The stent graft
main body is subsequently deployed. This will avoid trap-
ping the compliant AOB between the aortic neck and the
stent graft. This temporary deﬂation of the AOB rarely
results in Hd collapse and usually is of little consequence.
In Hd-unstable patients, the occlusion balloon can be
redirected into the aortic neck from the side ipsilateral to
the stent graft main body and reinﬂated at the infrarenal
aortic neck within the stent graft main body. This allows
for aortic occlusion and does not interfere with the
remainder of the endovascular procedure.
Implementation of a standardized protocol for emer-
gent r-EVAR has been demonstrated to improve outcomes
and allow for emergent treatment of Hd-unstable patients
in our experience, as well as others. Moore et al18 demon-
strated evidence of a signiﬁcant reduction in mortality
(17.9% vs 30%; P< .05) after introduction on an emergency
endovascular therapy protocol for r-AAA. A signiﬁcant
percentage of r-AAA patients present with Hd instability,
and without a standardized protocol, these patients are
often not considered suitable for EVAR and undergo
OSR.19 It is these Hd-unstable patients who have the high-
est mortality of OSR and might be the ones to experience
the greatest beneﬁt of EVAR, and further studies on Hd-
unstable r-AAA patients are needed.20 Lastly, health care
cost implications play a major role in evolution of treatments
and technology, and a recent report by Hayes et al21 in the
cost-effectiveness analysis of EVAR vs OSR of r-AAAs,
based on worldwide experience, indicates signiﬁcant cost
reduction and improvements in quality-adjusted life-years
in patients who undergo EVAR.
Our study has some inherent weaknesses. It is a non-
randomized study, and the Hd stability status was predeter-
mined on the basis of sustained SBP of <80 mm Hg for
>10 minutes before r-EVAR. Although we have deﬁned
preoperative Hd instability, the transient times from patient
presenting to outside institutions vs our medical center
where r-EVAR was performed are lacking, and there is
a selection bias in the survivors of r-AAAs who did undergo
EVAR. We were not able to analyze anatomic inclusion
and exclusion criteria for particular stent grafts to better
understand the implications of favorable vs unfavorable
aortoiliac morphology during emergent r-EVAR. Lastly,
we could not account for the surgeon’s selection bias in
treating the Hd-stable as well as Hd-unstable patient via
EVAR; surely, many Hd-unstable patients during the
course of this study with favorable and unfavorable aortoil-
iac morphology for EVAR underwent OSR who were not
included in this analysis.
CONCLUSIONS
The ﬁndings of this study suggest that r-EVAR is
feasible and relatively safe, regardless of the patient’s Hdstatus before repair. However, Hd-stable patients do have
a signiﬁcant early survival advantage. Our ﬁndings also
suggest that the patient’s Hd status does not affect nonfatal
complications and secondary interventions after EVAR. An
evaluation of the outcomes of Hd-unstable r-AAA patients
who undergo r-EVAR vs OSR was beyond the scope of this
analysis; historically, it is well reported that emergent OSR
in all-comers is associated with mortality rates of 40% to
70%. Even the most contemporary data would suggest
that the lowest r-OSR mortality rates are w35%.20 It
would be reasonable to speculate that Hd-unstable patients
who undergo emergent OSR would tend to have a higher
mortality, substantially higher than the 33% mortality of r-
EVAR. Therefore r-EVAR could be considered the ﬁrst-
line therapy in all r-AAA patients, regardless of their Hd
status. Although future randomized studies22,23 will
further enhance our understanding of how patients’ Hd
status might impact outcomes, this nonrandomized study
is the ﬁrst r-EVAR analysis based on patient Hd status,
and the outcomes identify several important variables that
negatively affect survival after r-EVAR in Hd-unstable
patients. The need for AOB and development of ACS are
factors that negatively affect survival in an Hd-unstable
patient. We hope that improvements in AAA awareness,
diagnosis, and treatments will continue to evolve and
improve our abilities to diagnose rupture early, and imple-
ment strategies to diagnose and prevent ACS.AUTHOR CONTRIBUTIONS
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